Hims & Hers Health Expects Q3 Revenue Of $375M - $380M, Est $323.89M
Portfolio Pulse from Benzinga Newsdesk
Hims & Hers Health expects Q3 revenue to be between $375M and $380M, significantly higher than the estimated $323.89M. The company also projects an adjusted EBITDA of $35M to $40M, reflecting a margin of 9% to 11%.
August 05, 2024 | 8:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health expects Q3 revenue to be between $375M and $380M, significantly higher than the estimated $323.89M. The company also projects an adjusted EBITDA of $35M to $40M, reflecting a margin of 9% to 11%.
The significant increase in projected revenue compared to estimates and the healthy adjusted EBITDA margin are positive indicators for Hims & Hers Health. This is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100